Login
Home
Charts
Search
Watchlist
Products

Influx Healthtech Ltd

INFLUX·NSE
275.00-0.38%Tue, 22 Sept '26 12:40

Influx Healthtech Ltd

INFLUX
NSE
275.00
-0.38%
|Tue, 22 Sept '26 12:40
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
641Cr
Close
Close Price
276.90
Industry
Industry
Pharma - Formulators
PE
Price To Earnings
31.22
PS
Price To Sales
4.37
Revenue
Revenue
147Cr
Rev Gr TTM
Revenue Growth TTM
PAT Gr TTM
PAT Growth TTM

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
Quarter
Revenue
RevenueCr
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
Operating Profit
Operating ProfitCr
OPM
OPM%
Other Income
Other IncomeCr
Interest Expense
Interest ExpenseCr
Depreciation
DepreciationCr
PBT
PBTCr
Tax
TaxCr
PAT
PATCr
Growth YoY
PAT Growth YoY%
NPM
NPM%
EPS
EPS
Quarter
Revenue
RevenueCr
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
Operating Profit
Operating ProfitCr
OPM
OPM%
Other Income
Other IncomeCr
Interest Expense
Interest ExpenseCr
Depreciation
DepreciationCr
PBT
PBTCr
Tax
TaxCr
PAT
PATCr
Growth YoY
PAT Growth YoY%
NPM
NPM%
EPS
EPS

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2026
Revenue
RevenueCr
147
Growth
Revenue Growth%
Expenses
ExpensesCr
117
Operating Profit
Operating ProfitCr
30
OPM
OPM%
20.3
Other Income
Other IncomeCr
1
Interest Expense
Interest ExpenseCr
0
Depreciation
DepreciationCr
4
PBT
PBTCr
27
Tax
TaxCr
7
PAT
PATCr
21
Growth
PAT Growth%
NPM
NPM%
14.0
EPS
EPS
9.3
Financial YearMar 2026
Revenue
RevenueCr
147
Growth
Revenue Growth%
Expenses
ExpensesCr
117
Operating Profit
Operating ProfitCr
30
OPM
OPM%
20.3
Other Income
Other IncomeCr
1
Interest Expense
Interest ExpenseCr
0
Depreciation
DepreciationCr
4
PBT
PBTCr
27
Tax
TaxCr
7
PAT
PATCr
21
Growth
PAT Growth%
NPM
NPM%
14.0
EPS
EPS
9.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial Year
Equity Capital
Equity CapitalCr
Reserves
ReservesCr
Current Liabilities
Current LiabilitiesCr
Non Current Liabilities
Non Current LiabilitiesCr
Total Liabilities
Total LiabilitiesCr
Current Assets
Current AssetsCr
Non Current Assets
Non Current AssetsCr
Total Assets
Total AssetsCr
Financial Year
Equity Capital
Equity CapitalCr
Reserves
ReservesCr
Current Liabilities
Current LiabilitiesCr
Non Current Liabilities
Non Current LiabilitiesCr
Total Liabilities
Total LiabilitiesCr
Current Assets
Current AssetsCr
Non Current Assets
Non Current AssetsCr
Total Assets
Total AssetsCr

Cash Flow

Consolidated
Standalone
Financial YearMar 2026
Operating Cash Flow
Operating Cash FlowCr
4
Investing Cash Flow
Investing Cash FlowCr
-25
Financing Cash Flow
Financing Cash FlowCr
45
Net Cash Flow
Net Cash FlowCr
23
Free Cash Flow
Free Cash FlowCr
CFO To PAT
CFO To PAT%
18.9
CFO To EBITDA
CFO To EBITDA%
13.0
Financial YearMar 2026
Operating Cash Flow
Operating Cash FlowCr
4
Investing Cash Flow
Investing Cash FlowCr
-25
Financing Cash Flow
Financing Cash FlowCr
45
Net Cash Flow
Net Cash FlowCr
23
Free Cash Flow
Free Cash FlowCr
CFO To PAT
CFO To PAT%
18.9
CFO To EBITDA
CFO To EBITDA%
13.0

Ratios

Consolidated
Standalone
Financial YearMar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
468641
Price To Earnings
Price To Earnings
22.831.2
Price To Sales
Price To Sales
3.24.4
Price To Book
Price To Book
4.66.4
EV To EBITDA
EV To EBITDA
20.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
20.320.3
NPM
NPM%
14.014.0
ROCE
ROCE%
ROE
ROE%
ROA
ROA%
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
468641
Price To Earnings
Price To Earnings
22.831.2
Price To Sales
Price To Sales
3.24.4
Price To Book
Price To Book
4.66.4
EV To EBITDA
EV To EBITDA
20.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
20.320.3
NPM
NPM%
14.014.0
ROCE
ROCE%
ROE
ROE%
ROA
ROA%
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Influx Healthtech Ltd

  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/kwfv9ox4trsf3a83f084pimv.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/nnmvm38os57aqo08jeqppk5v.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/alpi6gx9fzjliiqh2hum63p2.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/4xm9650px5mp67mp7jvuxpli.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/aseeo29jempvehhbt67hwawn.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/vkde40oytjk36oyn9hl9plm0.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/qdzuhh42bf9r6uakot7w9tyr.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/zwvk7yj0tadgjkx4yz76iq9x.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/r07xz8wnpjlt5ekznkelajzu.pdf

Concall Transcript Summaries — Influx Healthtech Ltd

  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AINFLUX/transcript-notes/202603/kwfv9ox4trsf3a83f084pimv.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AINFLUX/transcript-notes/202509/nnmvm38os57aqo08jeqppk5v.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AINFLUX/transcript-notes/202506/alpi6gx9fzjliiqh2hum63p2.pdf